Literature DB >> 6995839

Frequency of relapse and primaquine resistance in Southeast Asian vivax malaria.

W A Krotoski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995839     DOI: 10.1056/NEJM198009043031022

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 2.  In search of healers--Southeast Asian refugees in the American health care system.

Authors:  M A Muecke
Journal:  West J Med       Date:  1983-12

3.  Health care problems of Southeast Asian refugees.

Authors: 
Journal:  West J Med       Date:  1982-01

4.  Plasmodium vivax polymorphism in a clinical drug trial.

Authors:  T Adak; N Valecha; V P Sharma
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 5.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 6.  Artemisinin combination therapy for vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Brian J Angus; Francois Nosten; Ric N Price
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

7.  Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand.

Authors:  Chaturong Putaporntip; Thongchai Hongsrimuang; Sunee Seethamchai; Teerayot Kobasa; Kriengsak Limkittikul; Liwang Cui; Somchai Jongwutiwes
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

Review 8.  Malaria prophylaxis: taking aim at constantly moving targets.

Authors:  F J Bia
Journal:  Yale J Biol Med       Date:  1992 Jul-Aug

Review 9.  Malaria Elimination: Time to Target All Species.

Authors:  Andrew A Lover; J Kevin Baird; Roly Gosling; Ric N Price
Journal:  Am J Trop Med Hyg       Date:  2018-05-10       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.